SMARCD3 and neoplasm: Furthermore, SMARCD3 deletion reduced p-Src levels in MED8A and D458 cells and in xenograft tumours derived from these cells (Fig. 7e,f and Extended Data Fig. 9b), suggesting that Src activation is induced by increased SMARCD3 expression.